• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性甲状旁腺功能亢进症:来自骨组织形态计量学的经验教训。

Primary hyperparathyroidism: lessons from bone histomorphometry.

作者信息

Eriksen Erik Fink

机构信息

University Department of Endocrinology, Aarhus Amtssygehus, Denmark.

出版信息

J Bone Miner Res. 2002 Nov;17 Suppl 2:N95-7.

PMID:12412784
Abstract

The chronic excessive hypersecretion of parathyroid hormone (PTH) in primary hyperparathyroidism (PHPT) has significant impact on bone remodeling. Bone turnover increases by about 50%, leading to increased resorption at the endosteal envelope, increased cortical porosity, and thinning of cortical bone. In cancellous bone a different response is seen. Despite stimulation of bone resorption and formation at the tissue level, osteoclastic resorption and osteoblastic bone formation at individual bone multicellular units (BMUs) are reduced. This causes reduced erosion depth, reduced bone formation rate, and decreased thickness of bone structural units (BSUs), and bone balance at individual BMUs is preserved and may even improve. Thus, PHPT causes cortical bone loss. At the same time, however, cancellous bone structure remains unchanged or even improved, which may offset cortical bone loss. This probably explains the preservation of bone mass demonstrated in long-term follow-up studies of patients with mild PHPT (S-Ca2+ < 2.80 mM). In severe cases of PHPT (S-Ca2+ > 3.00 mM), the negative effects on cortical bone may override the positive impact on cancellous bone, and lead to bone loss and increased risk of fracture.

摘要

原发性甲状旁腺功能亢进症(PHPT)中甲状旁腺激素(PTH)的慢性过度分泌对骨重塑有重大影响。骨转换增加约50%,导致骨内膜表面吸收增加、皮质骨孔隙率增加和皮质骨变薄。在松质骨中则观察到不同的反应。尽管在组织水平上骨吸收和形成受到刺激,但单个骨多细胞单位(BMU)处的破骨细胞吸收和成骨细胞骨形成减少。这导致侵蚀深度减小、骨形成率降低以及骨结构单位(BSU)厚度减小,并且单个BMU处的骨平衡得以维持甚至可能改善。因此,PHPT导致皮质骨丢失。然而,与此同时,松质骨结构保持不变甚至有所改善,这可能抵消皮质骨丢失。这可能解释了轻度PHPT患者(血清总钙[S-Ca2+]<2.80 mM)长期随访研究中所显示的骨量维持现象。在严重的PHPT病例(S-Ca2+>3.00 mM)中,对皮质骨的负面影响可能超过对松质骨的积极影响,并导致骨丢失和骨折风险增加。

相似文献

1
Primary hyperparathyroidism: lessons from bone histomorphometry.原发性甲状旁腺功能亢进症:来自骨组织形态计量学的经验教训。
J Bone Miner Res. 2002 Nov;17 Suppl 2:N95-7.
2
The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.原发性甲状旁腺功能亢进症中的骨骼:一篇聚焦于骨重塑、结构、骨量和骨折的综述
APMIS Suppl. 2001(102):1-52.
3
Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.骨形成减少和骨吸收增加:骨质疏松症治疗的合理靶点。
Osteoporos Int. 2003;14 Suppl 3:S2-8. doi: 10.1007/s00198-002-1340-9. Epub 2003 Mar 19.
4
Primary hyperparathyroidism and the skeleton.原发性甲状旁腺功能亢进与骨骼
Clin Endocrinol (Oxf). 2008 Jul;69(1):1-19. doi: 10.1111/j.1365-2265.2007.03162.x. Epub 2008 Jul 1.
5
[Bone histomorphometric analysis in primary hyperparathyroidism].[原发性甲状旁腺功能亢进症的骨组织形态计量学分析]
Nihon Rinsho. 1995 Apr;53(4):879-84.
6
Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.原发性甲状旁腺功能亢进症:手术治疗前及治疗后3年的骨骼结构、平衡和重塑
Bone. 2000 May;26(5):535-43. doi: 10.1016/S8756-3282(00)00260-X.
7
Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.间歇性甲状旁腺激素的骨骼作用:对骨重塑和结构的影响。
Bone. 2007 Jun;40(6):1447-52. doi: 10.1016/j.bone.2006.09.008. Epub 2006 Oct 12.
8
Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism.微模型化可降低继发性甲状旁腺功能亢进患者皮质骨丢失率。
Am J Kidney Dis. 2007 Mar;49(3):440-51. doi: 10.1053/j.ajkd.2006.11.045.
9
Significance of primary hyperparathyroidism in the management of osteoporosis.原发性甲状旁腺功能亢进在骨质疏松症管理中的意义。
Otolaryngol Clin North Am. 2004 Aug;37(4):751-61, viii-ix. doi: 10.1016/j.otc.2004.02.007.
10
Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.接受甲状旁腺激素1-84治疗的绝经后骨质疏松症女性髂嵴处的松质骨和皮质骨结构及骨转换情况。
Bone. 2009 Jan;44(1):113-9. doi: 10.1016/j.bone.2008.09.019. Epub 2008 Oct 17.

引用本文的文献

1
Increased PHOSPHO1 and alkaline phosphatase expression during the anabolic bone response to intermittent parathyroid hormone delivery.在间歇给予甲状旁腺激素时,骨合成反应中 PHOSPHO1 和碱性磷酸酶的表达增加。
Cell Biochem Funct. 2023 Mar;41(2):189-201. doi: 10.1002/cbf.3772. Epub 2022 Dec 20.
2
Secondary Osteoporosis and Metabolic Bone Diseases.继发性骨质疏松症和代谢性骨病
J Clin Med. 2022 Apr 24;11(9):2382. doi: 10.3390/jcm11092382.
3
How To Build a Bone: PHOSPHO1, Biomineralization, and Beyond.如何构建骨骼:PHOSPHO1、生物矿化及其他
JBMR Plus. 2019 Jul 7;3(7):e10202. doi: 10.1002/jbm4.10202. eCollection 2019 Jul.
4
The Impact of Type 2 Diabetes on Bone Fracture Healing.2型糖尿病对骨折愈合的影响。
Front Endocrinol (Lausanne). 2018 Jan 24;9:6. doi: 10.3389/fendo.2018.00006. eCollection 2018.
5
The Expression of PHOSPHO1, nSMase2 and TNAP is Coordinately Regulated by Continuous PTH Exposure in Mineralising Osteoblast Cultures.在矿化成骨细胞培养中,持续暴露于甲状旁腺激素(PTH)可协同调节PHOSPHO1、中性鞘磷脂酶2(nSMase2)和组织非特异性碱性磷酸酶(TNAP)的表达。
Calcif Tissue Int. 2016 Nov;99(5):510-524. doi: 10.1007/s00223-016-0176-9. Epub 2016 Jul 21.
6
Asymptomatic primary hyperparathyroidism.无症状原发性甲状旁腺功能亢进症。
J Clin Densitom. 2013 Jan-Mar;16(1):14-21. doi: 10.1016/j.jocd.2012.11.005.
7
Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results.原发性甲状旁腺功能亢进症患者甲状旁腺切除术前、后无症状性动脉高血压、代谢综合征和亚临床心血管器官损害:初步结果。
Int J Endocrinol. 2012;2012:408295. doi: 10.1155/2012/408295. Epub 2012 Jun 7.
8
What is the utility of distal forearm DXA in primary hyperparathyroidism?前臂远端 DXA 在原发性甲状旁腺功能亢进症中的应用价值是什么?
Oncologist. 2012;17(3):322-5. doi: 10.1634/theoncologist.2011-0285. Epub 2012 Jan 18.
9
Treatment of osteopenia.骨质疏松症的治疗。
Rev Endocr Metab Disord. 2012 Sep;13(3):209-23. doi: 10.1007/s11154-011-9187-z.
10
Mineral composition is altered by osteoblast expression of an engineered G(s)-coupled receptor.成骨细胞表达工程化 G(s)偶联受体可改变矿物质组成。
Calcif Tissue Int. 2011 Jul;89(1):10-20. doi: 10.1007/s00223-011-9487-z. Epub 2011 Apr 28.